The expression pattern of UDP-N-acetyl-α-D-galactosamine-polypeptide N-acetyl-galactosaminyl transferase-3 in squamous cell carcinoma of the esophagus

Pathobiology

Volumn 72, Issue 3, 2005, Pages 139-145

  Ishikawa, Makoto ^a,c   Kitayama, Joji ^a   Kohno, Kimitoshi ^b   Nagawa, Hirokazu ^a  

^a THE UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Carcinogenesis; Esophageal carcinoma; Esophageal dysplasia; Squamous cell carcinoma; UDP N acetyl D galactosamine polypeptide N acetylgalactosaminyl transferase 3 (GalNAc T3)

Indexed keywords

N ACETYLGALACTOSAMINYLTRANSFERASE; POLYPEPTIDE; URIDINE DIPHOSPHATE N ACETYLGALACTOSAMINE;

ADULT; ANTIBODY SPECIFICITY; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; DYSPLASIA; ESOPHAGUS; ESOPHAGUS MUCOSA; ESOPHAGUS RESECTION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE;

CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; N-ACETYLGALACTOSAMINYLTRANSFERASES; NEOPLASM PROTEINS; NEOPLASM STAGING; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 18744383328     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000084117     Document Type: Article

References (32)

1. Itzkowitz SH, Bloom EJ, Kokal WA, et al: A novel mucin antigen associated with prognosis in colorectal cancer patients. Cancer 1990;66:1960-1966.
2. Nakamori S, Mameyama M, Imaoka S, et al: Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: Clinicopathological and immunohistochemical study. Cancer Res 1993;53:3632-3637.
3. Nakagoe T, Fukushima K, Hirota M, et al: Immunohistochemical expression of sialyl Lex antigen in relation to survival of patients with colorectal carcinoma. Cancer 1993;72:2323-2330.
4. Bennett EP, Hassen H, Mandel U, et al: Cloning and characterization of close homologue of human UDP-N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-T3, designated GalNac-T6. Evidence for genetic but not functional redundancy. J Biol Chem 1999;274:25362-25370.
5. Dahiya R, Itzkowitz SH, Byrd JC, et al: Mucin oligosaccharide biosynthesis in human colonic cancerous tissues and cell lines. Cancer 1992;70:1467-1476.
6. Yang JM, Byrd JC, Siddiki BB, et al: Alteration of O-glycan biosynthesis in human colon cancer tissues. Glycobiology 1994;4:873-884.
7. Seko A, Ohkura T, Kitamua H, et al: Quantitative difference in GlcNA:β1 → 3 and GlcNA:β1 → 4 galactosyltransferase activities between human colonic adenocarcinomas and normal colonic mucosa. Cancer Res 1996;56:3468-3473.
8. Vavasseur F, Dole K, Yang J, et al: O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer. Eur Biochem 1994;222:415-424.
9. Shimodaira K, Nakayama J, Nakamura N, et al: Carcinoma-associated expression of core 2β-1,6-N-acetylglucosaminyltransferase gene in human colorectal cancer: Role of O-glycans in tumor progression. Cancer Res 1997;57:5201-5206.
10. Brockhausen I, Yang J, Dickinson N, et al: Enzymatic basis for sialyl-Tn expression in human colon cancer cells. Glycobiology 1998;15:595-603.
11. Wandall HH, Hassan H, Mirgorodskaya E, et al: Substrate specificities of three members of the human UDP-N-acetyl-α-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase family, GalNAc-T1, -T2, and -T3. J Biol Chem 1997;272:23503-23514.
12. Sutherlin ME, Nishimori I, Caffrey T, et al: Expression of three UDP-N-acetyl-α-D-galactosamine:polypeptide GalNAc N- acetylgalactosaminyltransferases in adenocarcinoma cell lines. Cancer Res 1997;57:4744-4748.
13. ten Hagen KG, Tetaert D, Hagen FK, et al: Characterization of a UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase that displays glycopeptide N-acetylgalactosaminyltransferase activity. J Biol Chem 1999;274:27867-27874.
14. Homa FL, Hollander T, Lehman DJ, et al: Isolation and expression of a cDNA clone encoding a bovine UDP-GalNAc:polypeptide N- acetylgalactosaminyltransferase. J Biol Chem 1993;268:12609-12616.
15. Hagen FK, Van Wuyckhuyse B, Tabak LA, et al: Purification, cloning, and expression of bovine UPD-GalNAc: polypeptide N-acetyl-galactosaminyltransferase. J Biol Chem 1993;268:18960-18965.
16. ten Hagen KG, Hagen FK, Baly MM, et al: Cloning and expression of a novel, tissue specifically expressed member of the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase family. J Biol Chem 1998;273:27749-27754.
17. White T, Bennett EP, Takio K, et al: Purification, and cDNA cloning of a human UDP-N-acetyl-α-D-galactosamine:polypeptide N- acetylgalactosaminyltransferase:polypeptide N-acetylgalactosaminyltransferase. J Biol Chem 1995;270:24156-24165.
18. Bennett EP, Hassen H, Clausen H, et al: cDNA cloning and expression of a novel human UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase. Polypeptide N- acetylgalactosaminyltransferase, GalNAc-T3. J Biol Chem 1996;27:17006-17012.
19. Kuwano H, Watanabe M, Sadanaga N, et al: Squamous epithelial dysplasia associated with squamous cell carcinoma of the esophagus. Cancer Lett 1993;72:141-147.
20. Dawsey SM, Lewin KJ, Wang GQ, et al: Squamous esophageal histology and subsequent risk of squamous cell carcinoma of the esophagus. A prospective follow-up study from Linxian, China. Cancer 1994;74:1686-1692.
21. Sobin LH, Wittekin C: 1997 UICC TNM Classification of Malignant Tumors, ed 5. New York, Wiley, 1997.
22. Nomoto M, Izumi H, Ise T, et al: Structural basis for the regulation of UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyl transferases-3 gene expression in adenocarcinoma cells. Cancer Res 1999;59:6214-6222.
23. Chetty R, Simelane S: p53 and cyclin A protein expression in squamous carcinoma of the oesophagus. Pathol Oncol Res 1999;5:193-196.
24. Shi ST, Yang GY, Wang LD, et al: Role of p53 gene mutations in human esophageal carcinogenesis: Results from immunohistochemical and mutation analyses of carcinomas and nearby non-cancerous lesions. Carcinogenesis 1999;20:591-597.
25. Hu H, Xia SH, Li AD, et al: Elevated expression of p63 protein in human esophageal squamous cell carcinomas. Int J Cancer 2002;102:580-583.
26. Mori M, Mimori K, Shiraishi T, et al: Altered expression of Fhit in carcinoma and precarcinomatous lesions of the esophagus. Cancer Res 2000;60:1177-1182.
27. Shibao K, Izumi H, Nakayama Y, et al: Expression of UDP-N-acetyl-α- D-galactosamine-polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in relation to differentiation and prognosis in patients with colorectal carcinoma. Cancer 2002;94:1939-1946.
28. Onitsuka K, Shibao K, Nakayama Y, et al: Prognostic significance of UDP-N-acetyl-alpha-D-galactosamine:polypeptide N- acetylgalactosaminyltransferase-3 (GalNAc-T3) expression in patients with gastric carcinoma. Cancer Sci 2003;94/1:32-36.
29. Dosaka-Akita H, Kinoshita I, Yamazaki K, et al: N-Acetylgalactosaminyl transferase-3 is a potential new marker for non-small cell lung cancers. Br J Cancer 2002;87:751-755.
30. Gu C, Oyama T, Li J, et al: Low expression of polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in lung adenocarcinoma: Impact on poor prognosis and early recurrence. Br J Cancer 2004;90:436-442.
31. Inoue M, Takahashi S, Yamashina I, et al: High density O-glycosylation of the MUC2 tandem repeat unit by N-acetylgalactosaminyltransferases-3 in colonic adenocarcinoma extracts. Cancer Res 2001;61:950-956.
32. Yamamoto S, Nakamori S, Tsujie M: Expression of uridine diphosphate N-acetyl-α-D-galactosamine: polypeptide N-acetylgalactosaminyl transferase-3 in adenocarcinoma of the pancreas. Pathobiology 2004;71:12-18.